Combination of carbon-ion beam and dual tyrosine kinase inhibitor, lapatinib, effectively destroys HER2 positive breast cancer stem-like cells.
Sei Sai(National Institutes for Quantum Science and Technology), Mitsuhiro Hayashi(Dokkyo Medical University)
PubMed
January 1, 2020
Cited by 14